KR101314439B1 - 덱스트로오스 함유 필름 코팅 제제 - Google Patents

덱스트로오스 함유 필름 코팅 제제 Download PDF

Info

Publication number
KR101314439B1
KR101314439B1 KR1020077026730A KR20077026730A KR101314439B1 KR 101314439 B1 KR101314439 B1 KR 101314439B1 KR 1020077026730 A KR1020077026730 A KR 1020077026730A KR 20077026730 A KR20077026730 A KR 20077026730A KR 101314439 B1 KR101314439 B1 KR 101314439B1
Authority
KR
South Korea
Prior art keywords
film
coating formulation
film coating
film layer
formulation
Prior art date
Application number
KR1020077026730A
Other languages
English (en)
Korean (ko)
Other versions
KR20080008362A (ko
Inventor
다케시 하마우라
스스무 하세가와
Original Assignee
다이이찌 산쿄 가부시키가이샤
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by 다이이찌 산쿄 가부시키가이샤 filed Critical 다이이찌 산쿄 가부시키가이샤
Publication of KR20080008362A publication Critical patent/KR20080008362A/ko
Application granted granted Critical
Publication of KR101314439B1 publication Critical patent/KR101314439B1/ko

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/26—Carbohydrates, e.g. sugar alcohols, amino sugars, nucleic acids, mono-, di- or oligo-saccharides; Derivatives thereof, e.g. polysorbates, sorbitan fatty acid esters or glycyrrhizin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A61K9/2806—Coating materials
    • A61K9/2833—Organic macromolecular compounds
    • A61K9/286—Polysaccharides, e.g. gums; Cyclodextrin
    • A61K9/2866—Cellulose; Cellulose derivatives, e.g. hydroxypropyl methylcellulose
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K31/00—Medicinal preparations containing organic active ingredients
    • A61K31/33—Heterocyclic compounds
    • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
    • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
    • A61K31/4164—1,3-Diazoles
    • A61K31/4178—1,3-Diazoles not condensed 1,3-diazoles and containing further heterocyclic rings, e.g. pilocarpine, nitrofurantoin
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/20—Pills, tablets, discs, rods
    • A61K9/28—Dragees; Coated pills or tablets, e.g. with film or compression coating
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P13/00—Drugs for disorders of the urinary system
    • A61P13/12—Drugs for disorders of the urinary system of the kidneys
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/04—Anorexiants; Antiobesity agents
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00—Drugs for disorders of the metabolism
    • A61P3/08—Drugs for disorders of the metabolism for glucose homeostasis
    • A61P3/10—Drugs for disorders of the metabolism for glucose homeostasis for hyperglycaemia, e.g. antidiabetics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/10—Drugs for disorders of the cardiovascular system for treating ischaemic or atherosclerotic diseases, e.g. antianginal drugs, coronary vasodilators, drugs for myocardial infarction, retinopathy, cerebrovascula insufficiency, renal arteriosclerosis
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P9/00—Drugs for disorders of the cardiovascular system
    • A61P9/12—Antihypertensives

Landscapes

  • Health & Medical Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • Animal Behavior & Ethology (AREA)
  • Engineering & Computer Science (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Organic Chemistry (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Epidemiology (AREA)
  • Diabetes (AREA)
  • Heart & Thoracic Surgery (AREA)
  • Cardiology (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Urology & Nephrology (AREA)
  • Endocrinology (AREA)
  • Child & Adolescent Psychology (AREA)
  • Vascular Medicine (AREA)
  • Emergency Medicine (AREA)
  • Biochemistry (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Medicinal Preparation (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
KR1020077026730A 2005-05-20 2006-05-19 덱스트로오스 함유 필름 코팅 제제 KR101314439B1 (ko)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
JPJP-P-2005-00147435 2005-05-20
JP2005147435 2005-05-20
PCT/JP2006/309994 WO2006123766A1 (fr) 2005-05-20 2006-05-19 Preparation recouverte d’un film contenant du dextrose

Publications (2)

Publication Number Publication Date
KR20080008362A KR20080008362A (ko) 2008-01-23
KR101314439B1 true KR101314439B1 (ko) 2013-10-07

Family

ID=37431334

Family Applications (1)

Application Number Title Priority Date Filing Date
KR1020077026730A KR101314439B1 (ko) 2005-05-20 2006-05-19 덱스트로오스 함유 필름 코팅 제제

Country Status (5)

Country Link
JP (1) JP4979577B2 (fr)
KR (1) KR101314439B1 (fr)
CN (1) CN101180052B (fr)
TW (1) TWI367756B (fr)
WO (1) WO2006123766A1 (fr)

Families Citing this family (9)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
KR101400653B1 (ko) * 2006-10-25 2014-05-27 다이이찌 산쿄 가부시키가이샤 포장재
TW200833325A (en) * 2006-12-26 2008-08-16 Daiichi Sankyo Co Ltd Pharmaceutical composition comprising ascorbic acid
TWI414310B (zh) * 2006-12-26 2013-11-11 Daiichi Sankyo Co Ltd 溶出性改善之醫藥品組成物
JP2008201711A (ja) * 2007-02-20 2008-09-04 Ss Pharmaceut Co Ltd システイン臭が低減された固形製剤
KR20100072317A (ko) * 2007-10-29 2010-06-30 다이이찌 산쿄 가부시키가이샤 필름 코팅 제제
JP5688799B2 (ja) * 2008-08-11 2015-03-25 第一三共株式会社 におい抑制方法
JP4803686B2 (ja) * 2010-08-31 2011-10-26 協和発酵キリン株式会社 苦味を呈する薬物を含有する顆粒および口腔内崩壊錠
CN102716100B (zh) * 2012-07-12 2013-08-07 南京正大天晴制药有限公司 一种含奥美沙坦酯的片剂及其制备方法
JP6360007B2 (ja) * 2015-06-12 2018-07-18 富士フイルム株式会社 薬物含有粒子の製造方法

Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003048852A (ja) 2000-11-21 2003-02-21 Sankyo Co Ltd 医薬組成物

Family Cites Families (4)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6419956B1 (en) * 1999-12-30 2002-07-16 Ancile Pharmaceuticals Odor-masking coating for a pharmaceutical preparation
EP1595540A1 (fr) * 2000-11-21 2005-11-16 Sankyo Company Limited Composition comprenant un antagoniste du recepteur de l'angiotensine II et un diuretique et leur utilisation pour le traitement de l'hypertension
JP4647851B2 (ja) * 2001-08-07 2011-03-09 日立マクセル株式会社 カメラモジュール
AU2004208615C1 (en) * 2003-01-31 2010-05-13 Daiichi Sankyo Company, Limited Medicine for prevention of and treatment for arteriosclerosis and hypertension

Patent Citations (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2003048852A (ja) 2000-11-21 2003-02-21 Sankyo Co Ltd 医薬組成物

Also Published As

Publication number Publication date
KR20080008362A (ko) 2008-01-23
TWI367756B (en) 2012-07-11
JPWO2006123766A1 (ja) 2008-12-25
WO2006123766A1 (fr) 2006-11-23
CN101180052B (zh) 2010-11-17
JP4979577B2 (ja) 2012-07-18
CN101180052A (zh) 2008-05-14
TW200719888A (en) 2007-06-01

Similar Documents

Publication Publication Date Title
KR101318032B1 (ko) 필름 코팅 제제
KR101314439B1 (ko) 덱스트로오스 함유 필름 코팅 제제
KR20100072317A (ko) 필름 코팅 제제
CA2724533C (fr) Formulation antipsychotique atypique stabilisee
JP5854571B2 (ja) におい抑制方法
HUE029446T2 (en) Coated tablet formulation and process
BR112018011085B1 (pt) Composição farmacêutica compreendendo doravirina, fumarato de tenofovir desoproxila e lamivudina e processo para sua preparação
KR101640958B1 (ko) 유효 성분이 경계를 사이에 두고 존재하여 이루어지는 의약 고형 제제
KR101670693B1 (ko) 변색 및 냄새가 억제된 필름 코팅정
JPH11147819A (ja) 安定化された医薬製剤
JP5744340B2 (ja) フィルムコーティング用組成物
KR102369679B1 (ko) 다파글리플로진 l-프롤린과 메트포르민을 포함하는 약제학적 복합제제
KR20210096162A (ko) 의약 조성물
CN109475557A (zh) 含有甲氨蝶呤的薄膜包衣片
WO2024084496A1 (fr) Compositions pharmaceutiques comprenant du maléate d'acalabrutinib
KR20170113459A (ko) 타다라필 및 암로디핀 함유 고형 복합제제
JP2024007795A (ja) エゼチミブ・ロスバスタチン配合錠

Legal Events

Date Code Title Description
A201 Request for examination
E902 Notification of reason for refusal
E701 Decision to grant or registration of patent right
GRNT Written decision to grant
FPAY Annual fee payment

Payment date: 20160831

Year of fee payment: 4

FPAY Annual fee payment

Payment date: 20180920

Year of fee payment: 6